Marcus Shallow
Yale University
4 Papers
40 Citations
Marcus Shallow is an academic researcher from Yale University. The author has contributed to research in topics: Medicine & DLCO. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
A neutrophil activation signature predicts critical illness and mortality in COVID-19.
Matthew L Meizlish,Alexander B Pine,Jason Bishai,George Goshua,Emily R. Nadelmann,Michael Simonov,C-Hong Chang,Hanming Zhang,Marcus Shallow,Parveen Bahel,Kent A. Owusu,Yu Yamamoto,Tanima Arora,Deepak Atri,Amisha Patel,Rana Gbyli,Jennifer M. Kwan,Christine Won,Charles S. Dela Cruz,Christina Price,Jonathan L. Koff,Brett King,Henry M. Rinder,F. Perry Wilson,John Hwa,Stephanie Halene,William Damsky,David van Dijk,Alfred Ian Lee,Hyung J. Chun +29 more
TL;DR: In this paper, the authors carried out proteomic profiling of plasma from cross-sectional and longitudinal cohorts of hospitalized patients with COVID-19 and analyzed clinical data from a health system database of more than 3300 patients.
284
A neutrophil activation signature predicts critical illness and mortality in COVID-19.
Matthew L Meizlish,Alexander B Pine,Jason Bishai,George Goshua,Emily R. Nadelmann,Michael Simonov,C-Hong Chang,Hanming Zhang,Marcus Shallow,Parveen Bahel,Kent A. Owusu,Yu Yamamoto,Tanima Arora,Deepak Atri,Amisha Patel,Rana Gbyli,Jennifer M. Kwan,Christine Won,Charles S. Dela Cruz,Christina Price,Jonathan L. Koff,Brett King,Henry M. Rinder,F. Perry Wilson,John Hwa,Stephanie Halene,William Damsky,David van Dijk,Alfred Ian Lee,Hyung J. Chun +29 more
TL;DR: An essential role for neutrophil activation in the pathogenesis of severe COVID-19 is defined and molecular neutrophIL markers that distinguish patients at risk of future clinical decompensation are identified.
Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection.
Hyung J. Chun,Elias Coutavas,Alexander B Pine,Alfred Ian Lee,Vanessa L Yu,Marcus Shallow,Coral X. Giovacchini,Anne M. Mathews,Brian Stephenson,Loretta G. Que,Patty J. Lee,Bryan Kraft +11 more
TL;DR: In this paper, the authors performed a prospective cohort study of individuals with persistent symptoms after acute COVID-19, collecting clinical data, pulmonary function tests, and plasma samples used for multiplex profiling of inflammatory, metabolic, angiogenic, and fibrotic factors.
Immuno-fibrotic drivers of impaired lung function in post-COVID-19 syndrome
Hyung J. Chun,Elias Coutavas,Alexander B Pine,Alfred Ian Lee,Vanessa L Yu,Marcus Shallow,Coral X. Giovacchini,Anne M. Mathews,Brian Stephenson,Loretta G. Que,Patty J. Lee,Bryan Kraft +11 more
TL;DR: In this article, a prospective cohort study of subjects with persistent symptoms after recovering from acute COVID-19 illness, collecting clinical data, pulmonary function tests, and blood samples were used for multiplex profiling of circulating factors associated with inflammation, metabolism, angiogenesis, and fibrosis.